SCHEMBL24377095

SCHEMBL24377095

c1ccc(-c2ccccc2-c2ccccc2-c2ccc3cc(-c4nc(-c5ccc6ccccc6c5)nc(-c5ccc6ccccc6c5)n4)ccc3c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.50
KDM4E B2RXH2 3/20 0.49
MEN1 O00255 3/20 0.49
ALDH1A1 P00352 3/20 0.49
KMT2A Q03164 3/20 0.49
CYP1A2 P05177 2/20 0.49
HSD17B10 Q99714 2/20 0.49
TP53 P04637 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ADORA2A P29274 2/20 0.47
ADORA1 P30542 2/20 0.47
HDAC4 P56524 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
CYP1A1 P04798 1/20 0.46
CYP1B1 Q16678 1/20 0.46
CYP17A1 P05093 1/20 0.44
CYP19A1 P11511 1/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24377165 0.98 GSTP1 (0.52) GSTP1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL24377070 0.96 GSTP1 (0.50) GSTP1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL26154396 0.96 MEN1 (0.53) GSTP1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL27257527 0.94 MEN1 (0.54) GSTP1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL26154429 0.94 MEN1 (0.54) GSTP1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL21481419 0.93 MEN1 (0.47) GSTP1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL21481417 0.93 MEN1 (0.47) GSTP1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL24377036 0.93 HSD17B1 (0.49) GSTP1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL27252700 0.93 MEN1 (0.50) GSTP1KDM4EMEN1ALDH1A1KMT2A
SCHEMBL23633431 0.93 ALDH1A1 (0.49) GSTP1KDM4EMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220131082-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220131082-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, OR51E2, ETV6 GSTP1 2312/4885KDM4E 351/4885MEN1 1080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.